Sponsors (6)
The bill increases and stabilizes FDA funding and transparency for tobacco regulation and youth e‑cigarette prevention, improving oversight, but does so by expanding fee coverage and reporting requirements that raise costs for manufacturers (and potentially consumers) and create proprietary‑information and administrative burdens.
FDA will receive a larger, inflation‑adjusted user‑fee pool starting in FY2027, increasing funding for tobacco product review and regulatory activity.
Beginning in FY2029, user fees will apply across all tobacco product classes (including classes added by regulation), spreading costs more broadly across manufacturers and importers.
FDA must disclose and break down spending (including separate reporting on youth e-cigarette education and splits between deemed and combustible tobacco activities), increasing transparency about how fees are used for teen ENDS prevention and other efforts.
Manufacturers and importers, including small businesses, will face new reporting requirements and higher fee bills, increasing compliance costs for producers and potentially raising product prices.
Indexing the FDA user‑fee pool to CPI‑U will likely raise the total fees collected over time, increasing costs that may be passed on to consumers and taxpayers.
Collecting detailed sales and financial breakdowns risks exposing proprietary or sensitive business information about manufacturers and importers if redaction and privacy protections are insufficient.
Based on analysis of 3 sections of legislative text.
Increases and CPI-indexes the FDA tobacco user-fee pool, expands fees to all tobacco product classes by FY2029 with a sales-share allocation for new classes, and adds new annual reporting on ENDS spending and fee sources.
Introduced March 26, 2026 by Jeanne Shaheen · Last progress March 26, 2026
Raises and CPI-indexes the FDA’s annual tobacco-product user-fee pool, phases in assessment of fees on all classes of tobacco products by fiscal year 2029, and requires the FDA to use a sales-share formula (developed by regulation) to allocate fees to newly covered product classes. It also requires new annual report items showing spending and fee collections for deemed tobacco products (like e-cigarettes) versus combustible tobacco, and explains how FDA ensures user-fee funds support youth e-cigarette prevention education. The changes set fixed dollar levels for the near term, move to inflation adjustment thereafter, expand the classes of products that must pay fees, and add specific transparency and reporting requirements beginning in FY2027 and FY2029 to track expenditures and fee sources related to electronic nicotine delivery systems (ENDS) and other newly deemed products.